A randomized crossover trial to assess the effect of the Ma-Pi 2 MAcrobiotic diet in the treatment of reactive HYPoglycemia with continuous glucose monitoring system (MAHYP)

PM Un Punto Macrobiotico International Association (Italy)0 个研究点目标入组 12 人开始时间: 2016年2月5日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•1. Non-diabetic patients
•2. Both sexes
•3. Aged at least 18 years old
•4. BMI between 18 and 35 kg/m2
•5. Able to provide written informed consent and to follow the procedures of the protocol
•6. Previous diagnosis of RH, though it was confirmed by MMT before the enrolment

•1. Impaired fasting glucose/impaired glucose tolerance/diabetic patients
•2. Subjects affected by insulinoma or by other hypoglycemic endocrine conditions
•3. Patients affected by any neoplasia
•4. Patients affected by any food behavior disorders
•5. Pregnant women
•6. Symptoms of hypocalcemia
•7. Known or suspected hypersensitivity to any of the ingredients of the administered diets
•8. Patients under vitamin K antagonists or corticosteroid treatment
•9. Subjects under any drugs therapy which might interfere with glucose metabolism

发起方

PM Un Punto Macrobiotico International Association (Italy)